Vitamin D receptor (VDR) polymorphisms and skin cancer: A systematic review

Dermato-Endocrinology

Volumn 3, Issue 3, 2011, Pages 205-210

  Denzer, Nicole ^a   Vogt, Thomas ^a   Reichrath, Jörg ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Basal cell carcinoma; Melanoma; Polymorphism; Skin cancer; Squamous cell carcinoma; VDR; Vitamin D

Indexed keywords

VITAMIN D RECEPTOR;

BASAL CELL CARCINOMA; CANCER GROWTH; CANCER INCIDENCE; ENDOCRINE SYSTEM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; MELANOMA; PATHOGENESIS; PROGNOSIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN CANCER; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW;

EID: 80054026938     PISSN: 19381972     EISSN: 19381980     Source Type: Journal    
DOI: 10.4161/derm.16519     Document Type: Review

References (53)

1. English DR, Armstrong BK, Kricker A, Fleming C. Sunlight and cancer. Cancer Causes Control 1997; 8:271-83. (Pubitemid 27297796)
2. Ravanat JL, Douki T, Cadet J. Direct and indirect effects of UV radiation on DNA and its components. J Photochem Photobiol B 2001; 63:88-102. (Pubitemid 33040727)
3. Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, Holick MF. The role of vitamin D in cancer prevention. Am J Public Health 2006; 96:252-61. (Pubitemid 43167123)
4. Ingraham BA, Bragdon B, Nohe A. Molecular basis of the potential of vitamin D to prevent cancer. Curr Med Res Opin 2008; 24:139-49. (Pubitemid 351160247)
5. Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, et al. Cloning the expression of full length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 1988; 85:3294-8.
6. 3 in intestinal tract, stomach, kidney, skin, pituitary and parathyroid. Science 1979; 209:1189-90.
7. Haussler MR, Mangelsdorf DJ, Komm BS, Terpening CM, Yamaoka K, Allegretto EA, et al. Molecular biology of vitamin D hormone. Recent Prog Horm Res 1988; 44:263-305.
8. 3 signalling. Nature 1992; 355:446-9.
9. Labuda M, Fujiwara TM, Ross MV, Morgan K, Garcia Heras J, et al. Two hereditary defects related to vitamin D metabolism map to the same region of human chromosome 12q13-4. J. Bone Miner Res 1992; 7:1447-53.
10. Yu VC, Deisert C, Andersen B. RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone and vitamin D receptors to their cognate response elements. Cell 1991; 67:1251-66. (Pubitemid 121001537)
11. Leid M, Kastner P, Lyons R. Purification, cloning and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 1992; 68:377-95.
12. Hutchinson PE, Osborne JE, Lear JT, Smith AG, Bowers PW, Morris PN, et al. Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin Cancer Res 2000; 2:498-504. (Pubitemid 30111470)
13. Uitterlinden AG, Pols HA, Burger H, Huang Q, Van Daele PL, van Dujin CM, et al. A large-scale population-based study of the association of vitamin D receptor gene polymorphisms with bone mineral density. J Bone Miner Res 1996; 11:1241-8. (Pubitemid 26282524)
14. Fang Y, van Meurs JB, d'Alesio A, Jhamai M, Zhao H, Rivadeneira F, et al. Promoter und 3′-untranslated region haplotypes in the vitamin D receptor gene predispose to osteoporotic fracture: the Rotterdam study. Am J Hum Gent 2005; 77:807-23. (Pubitemid 41513282)
15. Barroso E, Fernandez LP, Milne RL, Pita G, Sendagorta E, Floristan U, et al. Genetic analysis of the vitamin D receptor gene in two epithelial cancers: melanoma and breast cancer case-control studies. BMC Cancer 2008; 8:385.
16. Gapska P, Scott RJ, Serrano-Fernandez P, Mirecka A, Rassoud I, Górski B, et al. Vitamin D receptor variants and the malignant melanoma risk: a population-based study. Cancer Epidemiol 2009; 33:103-7.
17. Randerson-Moor JA, Taylor JC, Elliott F, Chang YM, Beswick S, Kukalizch K, et al. Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels and melanoma: UK case-control comparisons and a meta-analysis of published VDR data. Eur J Cancer 2009; 45:3271-81.
18. Halsall JA, Osborne JE, Epstein MP, Pringle JH, Hutchinson PE. The unfavorable effect of the A allele of the vitamin D receptor promoter polymorphism A-1012G has different mechanisms related to susceptibility and outcome of malignant melanoma. Dermatoendocrinol 2009; 1:54-7.
19. Mocellin S, Nitti D. Vitamin D receptor polymorphisms and the risk of cutaneous melanoma: a systematic review and meta-analysis. Cancer 2008; 113:2398-407.
20. Köstner K, Denzer N, Müller CS, Klein R, Tilgen W, Reichrath J. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res 2009; 29:3511-36.
21. Gandini S, Raimondi S, Gnagnarella P, Doré JF, Maisonneuve P, Testori A. Vitamin D and skin cancer: a meta-analysis. Eur J Cancer 2009; 45:634-41.
22. Halsall JA, Osborne JE, Potter L, Pringle JH, Hutchinson PE. A novel polymorphism in the I A promoter region of the vitamin D receptor is associated with altered susceptibility and prognosis in malignant melanoma. British Journal of Cancer 2004; 91:765-70. (Pubitemid 39141638)
23. Santonocito C, Capizzi R, Concolino P, Lavieri MM, Paradisi A, Gentileschi S, et al. Association between cutaneous melanoma, Breslow thickness and vitamin D receptor BsmI polymorphism. Br J Dermatol 2007; 156:277-82. (Pubitemid 46095955)
24. Han J, Colditz GA, Hunter DJ. Polymorphisms in the MTHFR and VDR genes and skin cancer risk Carcinogenesis 2007; 28:390-7. (Pubitemid 46321855)
25. Povey JE, Darakhshan F, Robertson K, Bisset Y, Mekky M, Rees J, et al. DNA repair gene polymorphisms and genetic predisposition to cutaneous melanoma. Carcinogenesis 2007; 28:1087-93. (Pubitemid 47072195)
26. Li C, Liu Z, Zhang Z, Strom SS, Gershenwald JE, Prieto VG, et al. Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma. J Invest Dermatol 2007; 127:276-80. (Pubitemid 46106902)
27. Li C, Liu Z, Wang LE, Gershenwald JE, Lee JE, Prieto VG, et al. Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non-Hispanic whites in Texas: a case-control study. Int J Cancer 2008; 122:2077-84. (Pubitemid 351441199)
28. Hustmyer FG, Deluca HF, Peacock M. Apa1, Bsm1, EcoRV and Taq1 polymorphisms at the human vitamin D receptor gene locus in Caucasians, Blacks and Asians. Hum Mol Genet 1993; 2:487. (Pubitemid 23107234)
29. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367:284-7. (Pubitemid 24051146)
30. Ma J, Stampfer MJ, Gann PH, Hough HL, Giovannucci E, Kelsey KT, et al. Vitamin D receptor polymorphisms, circulating Vit D metabolites and risk of prostate cancer in United states physicians. Cancer Epidemiol Biomarkers Prev 1998; 7:385-90. (Pubitemid 28354126)
31. Morrison NA, Yeoman R, Kelly PJ, Eisman JA. Contribution of transactivating factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci USA 1992; 89:6665-9.
32. Jurutka PW, Whitfield GK, Hsieh JC, Tompson PD, Haussler CA, Haussler MR. Molecular nature of vitamin D receptor and its role in regulation of gene expression. Rev Endocrin Metab Disord 2001; 2:203-16. (Pubitemid 33635523)
33. Gross C, Eccleshall TR, Mallory PJ, Villa ML, Marcus R, Feldman D. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican American women. J Bone Miner Res 1996; 11:1850-5. (Pubitemid 26425676)
34. Saijo T, Ito M, Takeda E, Huq AH, Naito E, Yokota I, et al. A unique mutation in the vitamin D receptor gene in three Japanese patients with vitamin D dependent rickets type II: utility of single strand conformation polymorphism analysis for heterozygous carrier detection. Am J Hum Genet 1991; 49:668-73. (Pubitemid 21891713)
35. Arai H, Miyamoto K, Taketani Y, Yamamoto H, Iemori Y, Morita K, et al. A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 1997; 12:915-21. (Pubitemid 27225001)
36. Whitfield GK, Remus LS, Jurutka PW, Zitzer H, Oza AK, Hope T, et al. Are human vitamin D receptor polymorphisms functionally significant? In: Vitamin D Endocrine system, Structural, Biological, Genetic and Clinical Aspects. Norman AW, Bouillon R, Thomasset M, Eds. Riverside, CA: University of California 2000; 817-23.
37. Jurutka PW, Remus LS, Whitfield GK, Thompson PD, Hsieh JC, Zitzer H, et al. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol 2000; 14:401-20. (Pubitemid 32260532)
38. Colin EM, Weel AE, Uitterlinden AG, Buurman CJ, Birkenhager JC, Pols HA, van Leeuwen JP. Consequences of vitamin D receptor gene polymorphisms for growths inhibition of cultured human peripheral blood mononuclear cells by 1,25-dihydroxyvitamin D3. Clin Endocrinol 2000; 52:211-6. (Pubitemid 30108268)
39. Faraco JM, Morrison NA, Baker A, Shin J, Frossard PM. Apa1 dimorphism at the human vitamin D receptor gene locus. Nucleid Acids Res 1989; 117:2150. (Pubitemid 19084283)
40. Carless MA, Kraska N, Lintell RE, Neale AC, Griffiths LR. Polymorphisms of the VDR gene are associated with presence of solar keratoses on the skin. British Journal of Dermatology 2008; 159:804-10.
41. Moy RL. Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000; 42:8-10.
42. Evans C, Cockerell CJ. Actinic keratosis: time to call a spade a spade. South Med J 2000; 93:734-6.
43. 3 responsiveness and non-familial susceptibility in psoriasis. Pharmacogenet Genomics 2005; 15:349-55.
44. Schug J, Overton GC. Modeling transcription factor binding sites with Gibbs Sampling and Minimum Description Length encoding. Proc Int Conf Intell Syst Mol Biol 1997; 5:268-71.
45. Rengarajan J, Szabo SJ, Glimcher LH. Transcriptional regulation of Th1/Th2 polarization. Immunol Today 2000; 21:479-83.
46. 3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 2001; 167:4974-80.
47. Yamamoto H, Miyamot K, Li B, Taketani Y, Kitano M, Inoue Y, et al. The caudal-related homeodomain Cdx-2 regulates vitamin D receptor gene expression in the small intestine. J Bone Minar Res 1999; 14:240-7. (Pubitemid 29066249)
48. Fang Y, van Meurs JB, Bergink AP, Hofman A, van Dujin CM, van Leeuwen JP, et al. Cdx-2 polymorphism in the promoter region of the human vitamin D receptor gene determines susceptibility to fracture in the elderly. J Bone Miner Res 2003; 18:1632-41. (Pubitemid 37022921)
49. Uitterlinden SG, Fang Y, van Meurs JB, Pols HA, van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004; 338:143-56. (Pubitemid 39094759)
50. Durrin LK, Haile RW, Ingles SA, Coetzee GA. Vitamin D receptor 3′-untranslated region polymorphisms: lack of effect on mRNA stability. Biochim Biophys Acta 1999; 1453:311-20. (Pubitemid 29146155)
51. Carling T, Rastad J, Akerström G, Westin G. Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors. J Clin Endocrinol Metab 1998; 83:2255-9. (Pubitemid 28503010)
52. Nürnberg B, Gräber S, Gärtner B, Geisel J, Pföhler C, Schadendorf D, et al. Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients. Anticancer Res 2009; 29:3669-74.
53. 3 levels are associated with breslow thickness at presentation and survival from melanoma. J Clin Oncol 2009; 27:5439-44.